Open access · OA via OpenAlex

Rapamycin Extends Life Span in ApcMin/+ Colon Cancer FAP Model

Manish Parihar, Sherry G. Dodds, Gene B. Hubbard, Martin A. Javors, Randy Strong, Paul Hasty, Z. Dave Sharp

Clinical Colorectal Cancer · 2020 · ▲ 40 citations

Deregulated nutrient-sensing Rapamycin / mTOR inhibition

＋ Sign in to save

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.1016/j.clcc.2020.08.006
Canonical: link ↗
Fetched: 2026-06-13 MST

Cite this

APA

Parihar, M., Dodds, S.G., Hubbard, G.B., Javors, M.A., Strong, R., Hasty, P., & Sharp, Z.D. (2020). Rapamycin Extends Life Span in ApcMin/+ Colon Cancer FAP Model. <em>Clinical Colorectal Cancer</em>. https://doi.org/10.1016/j.clcc.2020.08.006

Vancouver

Parihar M, Dodds SG, Hubbard GB, Javors MA, Strong R, Hasty P, et al. Rapamycin Extends Life Span in ApcMin/+ Colon Cancer FAP Model. Clinical Colorectal Cancer. 2020. doi:10.1016/j.clcc.2020.08.006.

BibTeX

@article{manish2020Rapamy, title = {Rapamycin Extends Life Span in ApcMin/+ Colon Cancer FAP Model}, author = {Manish Parihar and Sherry G. Dodds and Gene B. Hubbard and Martin A. Javors and Randy Strong and Paul Hasty and Z. Dave Sharp}, journal = {Clinical Colorectal Cancer}, year = {2020}, doi = {10.1016/j.clcc.2020.08.006}, }